Literature DB >> 11309272

Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor function.

A Gati1, N Guerra, J Giron-Michel, B Azzarone, E Angevin, A Moretta, S Chouaib, A Caignard.   

Abstract

Tumor-infiltrating p58+ T cells from a renal tumor were specifically expanded in response to tumor cell stimulation and cloned. These p58+ T cells were found to express a memory phenotype and corresponded to clonal TCRBV3 T-cell expansion. Functionally, p58(+) CTLs displayed a low lytic activity for HLA-A2 tumor and normal cells. However, this lytic activity was significantly increased after blockade of p58 with specific monoclonal antibodies. Interestingly, we demonstrated that stimulation by tumor cells was required to trigger the inhibitory effect of p58 on the lytic activity of antigen-specific CTLs and that stimulation of the inhibitory function of p58 by tumor cells correlated with an inhibition of nuclear factor-kappaB activation in p58+ tumor-specific CTLS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309272

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.

Authors:  Chiara Romagnani; Gabriella Pietra; Michela Falco; Enrico Millo; Paola Mazzarino; Roberto Biassoni; Alessandro Moretta; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-07       Impact factor: 11.205

2.  Comparison of circulating and intratumoral regulatory T cells in patients with renal cell carcinoma.

Authors:  Gati Asma; Gorrab Amal; Marrakchi Raja; Derouiche Amine; Chebil Mohammed; Ben Ammar Elgaaied Amel
Journal:  Tumour Biol       Date:  2015-01-07

Review 3.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

Review 4.  Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma.

Authors:  Pierre Combe; Eleonore de Guillebon; Constance Thibault; Clémence Granier; Eric Tartour; Stéphane Oudard
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

5.  Numbers matter: quantitative and dynamic analysis of the formation of an immunological synapse using imaging flow cytometry.

Authors:  Fariyal Ahmed; Sherree Friend; Thaddeus C George; Natasha Barteneva; Judy Lieberman
Journal:  J Immunol Methods       Date:  2009-06-12       Impact factor: 2.303

6.  KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

Authors:  Yayi He; Paul A Bunn; Caicun Zhou; Dan Chan
Journal:  Oncotarget       Date:  2016-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.